Works matching IS 00099104 AND DT 2020 AND VI 202 AND IP 3
Results: 16
The rise of complement in ANCA‐associated vasculitis: from marginal player to target of modern therapy.
- Published in:
- Clinical & Experimental Immunology, 2020, v. 202, n. 3, p. 403, doi. 10.1111/cei.13515
- By:
- Publication type:
- Article
Gut microbiome alterations in type 1 autoimmune pancreatitis after induction of remission by prednisolone.
- Published in:
- Clinical & Experimental Immunology, 2020, v. 202, n. 3, p. 308, doi. 10.1111/cei.13509
- By:
- Publication type:
- Article
Characterization of circulating immune cells in acute Kawasaki disease suggests exposure to different antigens.
- Published in:
- Clinical & Experimental Immunology, 2020, v. 202, n. 3, p. 263, doi. 10.1111/cei.13506
- By:
- Publication type:
- Article
Sarcopenia and high NLR are associated with the development of hyperprogressive disease after second‐line pembrolizumab in patients with non‐small‐cell lung cancer.
- Published in:
- Clinical & Experimental Immunology, 2020, v. 202, n. 3, p. 353, doi. 10.1111/cei.13505
- By:
- Publication type:
- Article
Food allergy promotes a Th2/Th17 response that drives house dust mite‐induced allergic airway inflammation in humanized mice.
- Published in:
- Clinical & Experimental Immunology, 2020, v. 202, n. 3, p. 300, doi. 10.1111/cei.13504
- By:
- Publication type:
- Article
Mucosal‐associated invariant T (MAIT) cells are activated in the gastrointestinal tissue of patients with combination ipilimumab and nivolumab therapy‐related colitis in a pathology distinct from ulcerative colitis.
- Published in:
- Clinical & Experimental Immunology, 2020, v. 202, n. 3, p. 335, doi. 10.1111/cei.13502
- By:
- Publication type:
- Article
Serum level of soluble urokinase plasminogen activator receptor (suPAR) as a disease severity marker of myasthenia gravis: a pilot study.
- Published in:
- Clinical & Experimental Immunology, 2020, v. 202, n. 3, p. 321, doi. 10.1111/cei.13499
- By:
- Publication type:
- Article
The alternative complement pathway in ANCA‐associated vasculitis: further evidence and a meta‐analysis.
- Published in:
- Clinical & Experimental Immunology, 2020, v. 202, n. 3, p. 394, doi. 10.1111/cei.13498
- By:
- Publication type:
- Article
Rapamycin‐based graft‐versus‐host disease prophylaxis increases the immunosuppressivity of myeloid‐derived suppressor cells without affecting T cells and anti‐tumor cytotoxicity.
- Published in:
- Clinical & Experimental Immunology, 2020, v. 202, n. 3, p. 407, doi. 10.1111/cei.13496
- By:
- Publication type:
- Article
Childhood allergy is preceded by an absence of gut lactobacilli species and higher levels of atopy‐related plasma chemokines.
- Published in:
- Clinical & Experimental Immunology, 2020, v. 202, n. 3, p. 288, doi. 10.1111/cei.13494
- By:
- Publication type:
- Article
Accumulation of amyloid beta in human glioblastomas.
- Published in:
- Clinical & Experimental Immunology, 2020, v. 202, n. 3, p. 325, doi. 10.1111/cei.13493
- By:
- Publication type:
- Article
Comprehensive flow cytometric reference intervals of leukocyte subsets from six study centers across Europe.
- Published in:
- Clinical & Experimental Immunology, 2020, v. 202, n. 3, p. 363, doi. 10.1111/cei.13491
- By:
- Publication type:
- Article
Primary pneumococcal peritonitis can be the first presentation of a familial complement factor I deficiency<sup>1</sup>.
- Published in:
- Clinical & Experimental Immunology, 2020, v. 202, n. 3, p. 379, doi. 10.1111/cei.13490
- By:
- Publication type:
- Article
Associations between clinical features and therapy with macrophage subpopulations and T cells in inflammatory lesions in the aorta from patients with Takayasu arteritis.
- Published in:
- Clinical & Experimental Immunology, 2020, v. 202, n. 3, p. 384, doi. 10.1111/cei.13489
- By:
- Publication type:
- Article
Emerging patterns of regulatory T cell function in tuberculosis.
- Published in:
- Clinical & Experimental Immunology, 2020, v. 202, n. 3, p. 273, doi. 10.1111/cei.13488
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Clinical & Experimental Immunology, 2020, v. 202, n. 3, p. 1, doi. 10.1111/cei.13328
- Publication type:
- Article